Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02305407
Other study ID # VCI2014
Secondary ID
Status Recruiting
Phase N/A
First received November 19, 2014
Last updated August 21, 2017
Start date March 2016
Est. completion date May 2018

Study information

Verified date August 2017
Source Huashan Hospital
Contact Yu Lei, MD
Phone +86 021 52889999
Email piliyouxia_lei@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Adult patients with moyamoya disease (MMD) are reported to suffer from considerable impairment of executive function/attention. Although reduced cerebrovascular reserve (CVR) in frontal areas has been detected by perfusion MRI and then confirmed to be associated with executive dysfunction in adult MMD, the structural and functional changes is still unclear with progression of executive dysfunction. Furthermore, it is very important to study the association between the neurocognitive and radiological improvement after surgical revascularization, so as to help detecting cerebral regions which are involved in executive deterioration or improvement after surgery. Then the investigators can determine whether these regions can be used as indicators to decide rational therapeutic schedule and timing of adult MMD with executive dysfunction.

Thus the aim of this study is to primarily find out the neuropsychological and radiological correlates in adult MMD, and then to quantitatively evaluate the effectiveness of surgical revascularization in prevention of executive dysfunction in adult MMD.


Description:

Previous studies of adult moyamoya disease (MMD) have revealed that vascular cognitive impairment (VCI) is the consequence of ischemic damage to dynamic factors such as cerebral hypoperfusion, rather than to cerebral gray matter. However, it is still unclear which regions are affected by MMD and how these regions respond to the progressive cognitive decline. In other way, the investigators need to detect spatial patterns in the brain activity of MMD in order to understand its pathophysiological nature.

Surgical revascularization has been accepted as the only effective form of treatment in preventing future ischemic episodes. However, its effectiveness in cognitive protection is still unknown. Thus, the investigators determine to quantitatively evaluate cognitive and radiological outcomes in adult MMD postoperatively and during follow-ups.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date May 2018
Est. primary completion date April 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Right-handed Chinese people aged over 18 years

- No evidence of recent or remote infarct in the cerebral cortical, basal ganglia, brainstem or cerebellum

- No evidence of recent or remote intracerebral hemorrhage

- Diagnosis confirmed by digital subtraction angiography (DSA) according to Suzuki scale

- No surgical intervention before recruitment

- Physically capable of cognitive testing

- Geographically accessible and reliable for follow-up.

Exclusion Criteria:

- Significant neurological diseases or psychiatric disorders that could affect cognition

- Other cerebrovascular diseases (such as atherosclerosis or vasculitides) likely to cause focal cerebral ischemia

- Concomitant cerebrovascular diseases (such as aneurysms or arteriovenous malformation) that need surgical intervention

- Severe systemic diseases

- Pregnant or perinatal stage women

- Any diseases likely to death within 2 yeas

- Taking drugs such as benzodiazepine clonazepam

- Any contraindications or allergy to aspirin

- Allergy to iodine or radiographic contrast media

- Past history of surgical revascularization

- Concurrent participation in any other experimental treatment trial

- Any condition that in the surgeon's judgment suggests the patient an unsuitable surgical candidate.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Surgical Revascularization
Most patients in this group will be performed combined procedures of superficial temporal to middle cerebral artery bypass (STA-MCA) and encephalo-duro-myo-synangiosis (EDMS). Patients not suitable for combined procedures will be performed EDMS.
Other:
Conservative treatment
Patients will be medically treated with antiplatelets, antiepileptics, antihypertensives and vasodilators depending on the presentation.

Locations

Country Name City State
China Department of Neurosurgery, Huashan Hospital Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Huashan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Neurocognitive outcomes at 3/6/12/24-month follow-up after surgical revascularization or conservative treatment. Measure neurocognitive outcomes with a battery of neuropsychological tests covering global cognition, executive, memory, language, and visuospatial functions. It involves the Mini-mental state examination (MMSE), the Memory and Executive Screening test (MES), the Trail Making Test (TMT), the Auditory Verbal Learning Test (AVLT), the verbal fluency test (VFT), the Rey-Osterrieth complex figure test (CFT), etc. 2 years
Secondary The number of participants who suffer from all stroke or death during 30 days to 24 months 24 months
Secondary The number of participants who suffer from all kinds of adverse events related to surgery. 30 days
Secondary Postoperative neurocognitive outcomes before discharge. Measure neurocognitive outcomes about 1 week after surgery according to participants' physical condition, using the tests mentioned in the primary outcome measurement. average of 1 week after surgery
Secondary Postoperative radiological outcomes before discharge. Measure cerebral perfusion simultaneously with neurocognitive testing, using the single photon emission computed tomography (SPECT). average of 1 week after surgery
Secondary The changes from baseline in modified Rankin scale (mRS) and national institutes of health stroke scale (NIHSS). at 7 days, 30 days, 3/6/12/24 months
Secondary The changes from baseline in single photon emission computed tomography (SPECT). 2 years
Secondary The changes from baseline in blood oxygen level-dependent functional magnetic resonance imaging (BOLD fMRI) during rest. Data analysis techniques include amplitude of frequency fluctuation (ALFF), regional homogeneity (ReHo), independent component analysis (ICA), voxel-based morphometry analysis (VBM), etc. 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT03785171 - Predicative Value of Multimodal MRI in Moyamoya Disease
Recruiting NCT05619068 - The Evolution and Prognosis of Moyamoya Disease
Recruiting NCT03613701 - Relationship Between Endothelial Progenitor Cells and Revascularization Effect of Moyamoya Disease
Recruiting NCT06041659 - Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia
Not yet recruiting NCT06051552 - Prognostic Prediction Model in Patients With Moyamoya Disease Undergoing Revascularization Surgery
Suspended NCT04064658 - Effects of Remote Ischemic Pre-Conditioning in Moyamoya Disease Patients N/A
Recruiting NCT03627975 - Effect of Surgical Revascularization on Hemorrhagic Moyamoya Disease N/A
Not yet recruiting NCT06330818 - Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients N/A
Recruiting NCT05332756 - Long-term Outcomes of Conservative Management in Patients With Moyamoya Disease and Their First-degree Relatives (LAMORA)
Recruiting NCT04890782 - Gut Microbiota in Patients With Moyamoya Disease
Completed NCT03162588 - Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya Phase 1/Phase 2
Completed NCT03072914 - Effects of Remote Ischemic Preconditioning With Postconditioning on Neurologic Outcome N/A
Recruiting NCT04917003 - Safety and Efficacy of Remote Ischemic Conditioning Combined EDAS on Ischemic Moyamoya Disease N/A
Completed NCT04012268 - The Safety and Efficacy of RIC on Adult Moyamoya Disease N/A
Not yet recruiting NCT04205578 - NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events Phase 3
Recruiting NCT02982135 - Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease N/A
Recruiting NCT02074111 - Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke N/A
Recruiting NCT04696094 - The Role of m6A RNA Modification in Moyamoya Disease
Completed NCT04906564 - RNF213 Variants and Collateral Vessels in Moyamoya Disease
Recruiting NCT05961748 - Registry of Multicenter Brain-Heart Comorbidity in China